PharmiWeb.com - Global Pharma News & Resources

Research and development - Press Releases

Date Title Company
24-May-2022 BRITISH TECHNOLOGY SHOWCASED AT 75th WORLD HEALTH ASSEMBLY Zilico
24-May-2022 Eagle Genomics Joins Nordic Medicon Valley Alliance Eagle Genomics
24-May-2022 Thermo Fisher Scientific and Qatar Genome Program Partner to Advance Precision Medicine Thermo Fisher Scientific
24-May-2022 Slovenian Consortium and Elsevier Establish Transformative Agreement Elsevier
24-May-2022 Qlucore adds another cancer diagnostics area Qlucore
24-May-2022 Pronalyse Unveils Therapeutic Enzyme Characterization Service for Your Drug Development Creative Proteomics
24-May-2022 Cytokine Unveils Tumor Necrosis Factors (TNF) Detection Service Creative Proteomics
24-May-2022 Creative Proteomics Lipidomics Platform Boosts Short Chain Fatty Acids Research Creative Proteomics
20-May-2022 SAE Media Group Announces the date for 2nd Annual Aseptic Processing Conference SAE Media Group
19-May-2022 RetInSight Fluid Monitor provides next evolutionary step in monitoring of neovascular age-related macular degeneration RetInSight
19-May-2022 LIVE NEWS: CPHI North America Defacto communications
17-May-2022 N4 Pharma highlights potential of Nuvec® as gene therapy delivery platform N4 Pharma
17-May-2022 Eagle Genomics’ Anthony Finbow to Discuss Microbiome Science’s Role in Transforming Food and Nutrition at Food 4 Future in Bilbao Eagle Genomics
17-May-2022 Study launched to investigate Covid-19 vaccine protection in young, immunosuppressed people Kidney Research UK
17-May-2022 New Hebrew U. Research Study of Zebrafish Ovaries Reveals New Structure That Has Implications for Human Reproduction Hebrew University
17-May-2022 Nouscom Announces Janssen Receives US FDA IND Clearance for VAC85135, an ‘Off-The-Shelf’ Cancer Immunotherapy Developed using Nouscom’s Proprietary Viral Vector Platform Nouscom
17-May-2022 Novo Holdings Portfolio Company F2G enters strategic collaboration with Shionogi to commercialise its new antifungal agent Olorofim in Europe and Asia F2G
17-May-2022 Shionogi & Co., Ltd. and F2G Ltd., Enter Strategic Collaboration to Develop and Commercialize the New Antifungal Agent Olorofim in Europe and Asia Shionogi & Co., Ltd
17-May-2022 Drug formulation company raises £1m investment Aston Particle Technologies
16-May-2022 CD Bioparticles Launches New Silica Particles for Magnetic Nucleic Acid Extraction CD Bioparticles